Growth Metrics

Resmed (RMD) Cash from Operations (2016 - 2025)

Resmed's Cash from Operations history spans 17 years, with the latest figure at 339745000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 10.08% year-over-year to 339745000.0; the TTM value through Dec 2025 reached 1914493000.0, up 29.68%, while the annual FY2025 figure was 1751588000.0, 25.0% up from the prior year.
  • Cash from Operations reached 339745000.0 in Q4 2025 per RMD's latest filing, down from 457321000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 578661000.0 in Q1 2025 to a low of 65657000.0 in Q3 2021.
  • Average Cash from Operations over 5 years is 270858150.0, with a median of 277698500.0 recorded in 2023.
  • Peak YoY movement for Cash from Operations: crashed 145.6% in 2021, then soared 541.0% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 219879000.0 in 2021, then crashed by 41.5% to 128636000.0 in 2022, then skyrocketed by 112.1% to 272832000.0 in 2023, then grew by 13.12% to 308623000.0 in 2024, then increased by 10.08% to 339745000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMD's Cash from Operations are 339745000.0 (Q4 2025), 457321000.0 (Q3 2025), and 538766000.0 (Q2 2025).